Malignant hyperthermia causing Gly2435Arg mutation of the ryanodine receptor facilitates ryanodine-induced calcium release in myotubes

British Journal of Anaesthesia

Volumn 83, Issue 6, 1999, Pages 855-861

  Brinkmeier, H ^a   Kramer J ^a   Kramer R ^a   Iaizzo, P A ^b   Baur, C ^a   Lehmann Horn, F ^a   Rudel R ^a  

^a UNIVERSITY OF ULM   (Germany)

^b UNIVERSITY OF MINNESOTA   (United States)

Author keywords

Ions, calcium; Malignant hyperthermia; Muscle skeletal, culture; Receptors, ryanodine

Indexed keywords

CALCIUM; RYANODINE; RYANODINE RECEPTOR;

ARTICLE; CALCIUM CELL LEVEL; CALCIUM TRANSPORT; CELL CULTURE; CHEMICAL REACTION KINETICS; CONTROLLED STUDY; HUMAN; HUMAN CELL; MALIGNANT HYPERTHERMIA; MYOTUBE; PHENOTYPE; POINT MUTATION; PRIORITY JOURNAL; SKELETAL MUSCLE;

EID: 0345440064     PISSN: 00070912     EISSN: None     Source Type: Journal    
DOI: 10.1093/bja/83.6.855     Document Type: Article

References (34)

1. Denborough MA, Lovell RRH. Anaesthetic deaths in a family. Lancet 1960; 2: 45
2. Gronert GA. Malignant hyperthermia. In: Engel AG, Franzini-Armstrong C, eds. Myology. Basic and Clinical, 2nd Edn. New York: McGraw-Hill, 1994; 1661-78
3. Denborough M. Malignant hyperthermia. Lancet 1998; 352: 1131-6
4. Phillips MS, Fujii J, Khanna VK, et al. The structural organization of the human skeletal muscle ryanodine receptor (RYRI) gene. Genomics 1996; 34: 24-41
5. 2+ regulation defects. Physiol Rev 1996; 76: 537-92
6. Manning BM, Quane KA, Ording H, et al. Identification of novel mutations in the ryanodine-receptor gene (RYRI) in malignant hyperthermia: genotype-phenotype correlation. Am J Hum Genet 1998; 62: 599-609
7. Barone V, Massa O, Intravaia E, et al. Mutation screening of the RYRI gene and identification of two novel mutations in Italian malignant hyperthermia families. J Med Genet 1999; 36: 115-18
8. Richter M, Schleithoff L, Deufel T, Lehmann-Horn F, Herrmann-Frank A. Functional characterization of a distinct ryanodine receptor mutation in human malignant hyperthermia-susceptible muscle. J Biol Chem 1997; 272: 5256-60
9. 3H]ryanodine binding to sarcoplasmic reticulum from malignant hyperthermia susceptible pigs. Arch Biochem Biophys 1990; 278: 251-7
10. Sudbrak R, Procaccio V, Klausnitzer M, et al. Mapping of a further malignant hyperthermia susceptibility locus to chromosome 3q13.1. Am J Hum Genet 1995; 56: 684-91
11. Iles DE, Lehmann Horn F, Scherer SW, et al. Localization of the gene encoding the alpha 2/delta-subunits of the L-type voltage-dependent calcium channel to chromosome 7q and analysis of the segregation of flanking markers in malignant hyperthermia susceptible families. Hum Mol Genet 1994; 3: 969-75
12. Robinson RL, Monnier N, Wolz W, et al. A genome wide search for susceptibility loci in three European malignant hyperthermia pedigrees. Hum Mol Genet 1997; 6: 953-61
13. Monnier N, Procaccio V, Stieglitz P, Lunardi J. Malignant-hyperthermia susceptibility is associated with a mutation of the alpha I-subunit of the human dihydropyridine-sensitive L-type voltage-dependent calcium-channel receptor in skeletal muscle. Am J Hum Genet 1997; 60: 1316-25
14. European MH group. A protocol for the investigation of malignant hyperpyrexia (MH) susceptibility. Br J Anaesth 1984; 56: 1267-9
15. Larach MG. Standardization of the caffeine halothane muscle contracture test. North American Malignant Hyperthermia Group. Anesth Analg 1989; 69: 511-15
16. Hartung E, Koob M, Anetseder M, et al. Malignant hyperthermia (MH) diagnostics: a comparison between the halothane-caffeine- and the ryanodine-contracture-test results in MH susceptible, normal and control muscle. Acta Anaesthesiol Scand 1996; 40: 437-44
17. Hopkins PM, Ellis FR, Halsall PJ, Stewart AD. An analysis of the predictive probability of the in vitro contracture test for determining susceptibility to malignant hyperthermia. Anesth Analg 1997; 84: 648-56
18. Ording H, Glahn K, Gardi T, Fagerlund T, Bendixen D. 4-Chloro-m-cresol test-a possible supplementary test for diagnosis of malignant hyperthermia susceptibility. Acta Anaesthesiol Scand 1997; 41: 967-72
19. Herrmann-Frank A, Richter M, Sarkozi S, Mohr U, Lehmann-Horn F. 4-Chloro-m-cresol, a potent and specific activator of the skeletal muscle ryanodine receptor. Biochim Biophys Acta 1996; 1289: 31-40
20. Gallant EM, Jordan RC. Porcine malignant hyperthermia: genotype and contractile threshold of immature muscles. Muscle Nerve 1996; 19: 68-73
21. Censier K, Urwyler A, Zorzato F, Treves S. Intracellular calcium homeostasis in human primary muscle cells from malignant hyperthermia-susceptible and normal individuals. Effect of overexpression of recombinant wild-type and Arg163Cys mutated ryanodine receptors. J Clin Invest 1998; 101: 1233-42
22. Uetz U, Pressmar J, Brinkmeier H, Iaizzo PA, Rüdel R, Lehmann-Horn F. Bestimmung der intrazellulären Kalziumkonzentration an menschlichen Skelettmuskelfasern und Myotuben von Patienten mit Anlage zur malignen Hyperthermie. Akt Neurol 1995; 22: S23
23. Brinkmeier H, Mutz JV, Seewald MJ, Melzner I, Rüdel R. Specific modifications of the membrane fatty acid composition of human myotubes and their effects on the muscular sodium channels. Biochim Biophys Acta 1993; 1145: 8-14
24. Föhr KJ, Warchol W, Gratzl M. Calculation and control of free divalent cations in solutions used for membrane fusion studies. Methods Enzymol 1993; 221: 149-57
25. 2+ indicators with greatly improved fluorescence properties. J Biol Chem 1985; 260: 3440-50
26. 2+ concentrations are not elevated in resting cultured muscle from Duchenne (DMD) patients and in MDX mouse muscle fibres. Pflügers Arch 1994; 426: 499-505
27. Kyselovic J, Leddy JJ, Ray A, Wigle J, Tuana BS. Temporal differences in the induction of dihydropyridine receptor subunits and ryanodine receptors during skeletal muscle development. J Biol Chem 1994; 269: 21770-7
28. Ray A, Kyselovic J, Leddy JJ, Wigle JT, Jasmin BJ, Tuana BS. Regulation of dihydropyridine and ryanodine receptor gene expression in skeletal muscle. Role of nerve, protein kinase C, and cAMP pathways. J Biol Chem 1995; 270: 25837-44
29. Schmoelzl S, Leeb T, Brinkmeier H, Brem G, Brenig B. Regulation of tissue-specific expression of the skeletal muscle ryanodine receptor gene. J Biol Chem 1996; 271: 4763-9
30. Tarroni P, Rossi D, Conti A, Sorrentino V. Expression of the ryanodine receptor type 3 calcium release channel during development and differentiation of mammalian skeletal muscle cells. J Biol Chem 1997; 272: 19808-13
31. Flucher BE, Andrews SB, Fleischer S, Marks AR, Caswell A, Powell JA. Triad formation: organization and function of the sarcoplasmic reticulum calcium release channel and triadin in normal and dysgenic muscle in vitro. J Cell Biol 1993; 123: 1161-74
32. Iaizzo PA, Klein W, Lehmann Horn F. Fura-2 detected myoplasmic calcium and its correlation with contracture force in skeletal muscle from normal and malignant hyperthermia susceptible pigs. Pflügers Arch 1988; 411: 648-53
33. 2+] in skeletal muscle fibers from control and malignant hyperthermia-susceptible swine. Anesthesiology 1992; 76: 132-8
34. 2+] measured in vivo in patients susceptible to malignant hyperthermia. Anesthesiology 1992; 76: 711-19